Archives: Agenda

• Managing inventory, procurement and logistics for manufacturing, storage and distribution
• Optimizing drug supply based on patient needs
• Enhancing traceability, security and transparency
• Ensuring regulatory compliance and GMP/GDP processes are documented and auditable

Discover how advanced digital enablement tools are transforming supply chain operations, offering real-time insights, and fostering confidence in supply continuity. Additionally, explore how operational innovations are redefining processes to deliver the speed and scalability required to support both biotech agility and biopharma complexity.

Attendees will gain actionable insights into:

• Strategies for reducing clinical supply waste while ensuring patient needs are met
• Digital tools that enhance real-time visibility into supply shipments and their status
• Operational innovations that enable faster timelines without increasing risk
• Practical approaches to aligning supply chain efficiency with clinical trial demand

Accelerate, cultivate, innovate!—managing relationships with the modern supplier
How Bayer’s external relationship governance model adds value to the business ensuring a reliable partnership and complements the sourcing & procurement functions within CTS scope

• Trends on procurement roles and the necessity to have an operational perspective
• Different approaches from different business necessities
• Trends on how to best manage CMOs, 3PLs and clinical trials partners

Join us as we discuss five key areas of preparation for regulatory inspections based on current industry trends:

• Audit trails
• Data Integrity – beyond ALCOA++
• Transparency and Responsibilities
• Randomization – keeping the blind in mind
• User Access Management

• Recognizing the increasing frequency of medicine shortages in Europe, and highlighting vulnerabilities in the supply chain
• Facilitating and sharing of critical medicines and resources among EU member states through the EMA MSSG Solidarity Mechanism, thereby improving supply chain resilience
• Promoting collaboration among healthcare providers

• Demands on commercial supply chain
• Direct influences on commercial CT supply
• Key sustainable sourcing practices
• Learning from the past – case studies

• Considering recent key geopolitical trends’ impact on the future of healthcare and pharma
• Investigating the cause of recurring supply chain disruptions
• Learning how to build supply chain resilience

• Ensuring temperature integrity in clinical trials
• How to overcome the bottle necks of the supply chain
• The role of Technology: Are your clinical trials future-proofed?

• Introduction to AstraZeneca’s Logistics and Clinical Supplies Vendor Selection Approach
• Vendor Qualification
• Qualified Vendor Selection
• Q&A